Synthetic Biologics, Inc. (19) | Uncategorized (5)

Recent Contracts

Description of Securities of Synthetic Biologics, Inc (Filed With SEC on March 16, 2022)
Technology Transfer Agreement between Bellvitge Biomedical Research Institute and VCN Biosciences S.L. dated August 31, 2010 (Filed With SEC on March 16, 2022)
DESCRIPTION OF SECURITIES REGISTERED PURSUANT TO SECTION 12OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED (Filed With SEC on March 4, 2021)
Description of Securities (Filed With SEC on February 20, 2020)
Clinical Trial Agreement between Washington University School of Medicine in St. Louis and Synthetic Biologics, Inc. dated August 7, 2019 (Filed With SEC on August 8, 2019)